Tumor invasion and distant metastasis remain major causes of treatment failure in lung adenocarcinoma (LUAD), thereby elucidating the molecular mechanisms is critical for precise treatment of LUAD. Using bulk RNA-Seq and single cell transcriptome data, combining with multi-machine learning methods, we identified GOLM1 as a core gene associated with poor prognosis in LUAD, which is highly expressed in malignant epithelial cells characterized by increased extracellular matrix (ECM)-integrin signaling, glycosylation remodelling and invasion-related transcriptional programs. Mechanistically, we validated that STAT1 is an upstream transcription activator of GOLM1 that forms a STAT1-GOLM1 axis that triggers LUAD invasion. Candidate compounds were prioritized by computational molecular docking against STAT1 and subsequently evaluated in A549 cells. Experimental validation revealed that Compound 1 exhibited the strongest inhibitory effect on LUAD cells by regulating PI3K/AKT signaling, cell-cycle and apoptosis. Collectively, our results elucidated the significant role of STAT1-GOLM1 axis in LUAD and provided a promising AI-directed inhibitor for LUAD.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: